NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|15833164|ref|NP_311937|]
View 

NADPH quinone reductase [Escherichia coli O157:H7 str. Sakai]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10495002)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
Gene Ontology:  GO:0050136|GO:0008753|GO:0010181
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.04e-42

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


:

Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 141.70  E-value: 1.04e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164     2 SNILIINGAKKFAHSNGQLNDTLTEvadgTLRDLGHDVRIV-------------------RADSDYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVE----ALKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164    63 VIWQMPGWWMGAPWTVKKYIDDVFTEghgtlyasdGRTRKDPSKKYGSGGLVqGKKYMLSLTWNAPMEAFTEKdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRA---------GFAFKYEEGGPGGGGLL-GKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 15833164   143 GVDGVYLPFHKANQFLGMEPLPTFIANDV---IKMPDVPRYTEEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
 
Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.04e-42

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 141.70  E-value: 1.04e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164     2 SNILIINGAKKFAHSNGQLNDTLTEvadgTLRDLGHDVRIV-------------------RADSDYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVE----ALKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164    63 VIWQMPGWWMGAPWTVKKYIDDVFTEghgtlyasdGRTRKDPSKKYGSGGLVqGKKYMLSLTWNAPMEAFTEKdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRA---------GFAFKYEEGGPGGGGLL-GKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 15833164   143 GVDGVYLPFHKANQFLGMEPLPTFIANDV---IKMPDVPRYTEEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-192 4.61e-24

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 93.37  E-value: 4.61e-24
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164   3 NILIIngakkFAHSNGQ-LNDTLTEVADGTLRDLGHDVRIV-----------RADSDY-------DVKAEVQNFLWADVV 63
Cdd:COG2249   1 KILII-----YAHPDPSsFNAALAEAAAEGLEAAGHEVTVHdlyaegfdpvlSAADFYrdgplpiDVAAEQELLLWADHL 75
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164  64 IWQMPGWWMGAPWTVKKYIDDVFTegHGTLYASDGRtrkdpskkyGSGGLVQGKKYMLSLTWNAPMEAFTE-------KD 136
Cdd:COG2249  76 VFQFPLWWYSMPALLKGWIDRVLT--PGFAYGYGGG---------YPGGLLKGKKALLVVTTGGPEEAYSRlgyggpiEE 144
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|....*...
gi 15833164 137 QFFHGVgvdgvylpFHkanqFLGMEPLPTFIANDVIKMPD--VPRYTEEYRKHLVEIF 192
Cdd:COG2249 145 LLFRGT--------LG----YCGMKVLPPFVLYGVDRSSDeeRAAWLERVRELLAALA 190
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
45-190 3.20e-05

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 42.46  E-value: 3.20e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164   45 DSDYDVKAEVQNFLWADVVIWQMPGWWMGAPWTVKKYIDDVFTEGHGtlyasdgrtrkdpskkYGSGGLVQGKKYMLslt 124
Cdd:PRK00871  41 DFNIDIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWA----------------YGHGGTALHGKHLL--- 101
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15833164  125 WNAPMEAftEKDQFFHGV--GVDGVYLPFHKANQFLGMEPLP------TFIANDvikmPDVPRYTEEYRKHLVE 190
Cdd:PRK00871 102 WAVTTGG--GESHFEIGAhpGFDVLSQPLQATALYCGLNWLPpfamhcTFICDD----ETLEGQARHYKQRLLE 169
 
Name Accession Description Interval E-value
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-188 1.04e-42

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 141.70  E-value: 1.04e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164     2 SNILIINGAKKFAHSNGQLNDTLTEvadgTLRDLGHDVRIV-------------------RADSDYDVKAEVQNFLWADV 62
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVE----ALKAAGHEVTVRdlyalflpvldaedladltYPQGAADVESEQEELLAADV 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164    63 VIWQMPGWWMGAPWTVKKYIDDVFTEghgtlyasdGRTRKDPSKKYGSGGLVqGKKYMLSLTWNAPMEAFTEKdqFFHGV 142
Cdd:pfam02525  77 IVFQFPLYWFSVPALLKGWIDRVLRA---------GFAFKYEEGGPGGGGLL-GKKVLVIVTTGGPEYAYGKG--GYNGF 144
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 15833164   143 GVDGVYLPFHKANQFLGMEPLPTFIANDV---IKMPDVPRYTEEYRKHL 188
Cdd:pfam02525 145 SLDELLPYLRGILGFCGITDLPPFAVEGTagpEDEAALAEALERYEERL 193
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-192 4.61e-24

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 93.37  E-value: 4.61e-24
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164   3 NILIIngakkFAHSNGQ-LNDTLTEVADGTLRDLGHDVRIV-----------RADSDY-------DVKAEVQNFLWADVV 63
Cdd:COG2249   1 KILII-----YAHPDPSsFNAALAEAAAEGLEAAGHEVTVHdlyaegfdpvlSAADFYrdgplpiDVAAEQELLLWADHL 75
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164  64 IWQMPGWWMGAPWTVKKYIDDVFTegHGTLYASDGRtrkdpskkyGSGGLVQGKKYMLSLTWNAPMEAFTE-------KD 136
Cdd:COG2249  76 VFQFPLWWYSMPALLKGWIDRVLT--PGFAYGYGGG---------YPGGLLKGKKALLVVTTGGPEEAYSRlgyggpiEE 144
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|....*...
gi 15833164 137 QFFHGVgvdgvylpFHkanqFLGMEPLPTFIANDVIKMPD--VPRYTEEYRKHLVEIF 192
Cdd:COG2249 145 LLFRGT--------LG----YCGMKVLPPFVLYGVDRSSDeeRAAWLERVRELLAALA 190
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
45-190 3.20e-05

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 42.46  E-value: 3.20e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164   45 DSDYDVKAEVQNFLWADVVIWQMPGWWMGAPWTVKKYIDDVFTEGHGtlyasdgrtrkdpskkYGSGGLVQGKKYMLslt 124
Cdd:PRK00871  41 DFNIDIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWA----------------YGHGGTALHGKHLL--- 101
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15833164  125 WNAPMEAftEKDQFFHGV--GVDGVYLPFHKANQFLGMEPLP------TFIANDvikmPDVPRYTEEYRKHLVE 190
Cdd:PRK00871 102 WAVTTGG--GESHFEIGAhpGFDVLSQPLQATALYCGLNWLPpfamhcTFICDD----ETLEGQARHYKQRLLE 169
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
3-83 4.05e-05

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 42.22  E-value: 4.05e-05
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15833164   3 NILIINGAKKfAHSNgqlNDTLTE-VADGtLRDLGHDVRIVRADS-----------------DYDVKAEVQNFLWADVVI 64
Cdd:COG0655   1 KILVINGSPR-KNGN---TAALAEaVAEG-AEEAGAEVELIRLADldikpcigcggtgkcviKDDMNAIYEKLLEADGII 75
                        90
                ....*....|....*....
gi 15833164  65 WQMPGWWMGAPWTVKKYID 83
Cdd:COG0655  76 FGSPTYFGNMSAQLKAFID 94
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH